Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the
相比竞争对手,Mauna Kea Technologies的DCF公允价值 (InvestingPro)基准如何? 我们发现下列公司与Mauna Kea Technologies SA相近,它们都属于相关的行业。我们还考虑了规模、增长和各种财务指标,并将列表缩小到以下范围。 Mauna Kea Technologies的DCF公允价值 (InvestingPro)基准 名称代码DCF公允价值 (InvestingPro) Mauna ...
以下为Mauna Kea Technologies SA实际一致营收数据要点 表现汇总 Mauna Kea Technologies的实际一致营收是11.57百万 过去5年,Mauna Kea Technologies的实际一致营收在December 2023达到了 11.57百万的峰值。 Mauna Kea Technologies的实际一致营收于December 2020触及5年低点,是7.972百万。
MAUNAKEATECHNOLOGIESSA目前是天士力莫纳康医学工程科技有限公司直接控股股东,持股比例为49%,是天士力莫纳康(天津)医学工程科技有限公司直接控股股东,持股比例为49%;MAUNAKEATECHNOLOGIESSA间接持股天士力莫纳康(天津)医学工程科技有限公司、投资占比达49%;目前MAUNAKEATECHNOLOGIESSA投资天士力莫纳康医学工程科技有限公司最终收益...
Mauna Kea Technologies SA formerly Mauna Kea Technologies SAS is a France-based medical device manufacturing company. The Company specializes in designing, developing, and selling optical biopsy devices and tools. Its products are intended for visualizing and detecting cellular abnormalities during the gas...
Mauna Kea Technologies SA (MKEAF) Frequently Asked Questions People Also Follow SymbolLast PriceChange IDYLF 0.03 0.00% Imaging Dynamics Company Ltd. EPSFF 0.45 0.00% Episurf Medical AB (publ) LFTSF 0.23 0.00% LifeTech Scientific Corporation ...
Forte de plus de 24 ans d’existence, Mauna Kea Technologies a su démontrer sa résilience en surmontant par le passé des défis similaires. La société continuera de fournir des mises à jour régulières sur l’avancement des initiatives financières, sur toute décision stratégique qui...
天士力医药集团股份有限公司(以下简称“天士力”)与法国Mauna Kea Technologies SA(以下简称“MKT”)的商业合作项目,近日完成签约和公告。君合代表天士力,为其和MKT设立合资公司及开展后续商业合作提供全程法律服务。 天士力是我国知名的医药企业,致力于发展成为中国领先,具有全球影响力的医药及健康服务集成方案提供者。天士力...